URACIL MUSTARD, A NEW ALKYLATING AGENT FOR ORAL ADMINISTRATION IN MANAGEMENT OF PATIENTS WITH LEUKEMIA AND LYMPHOMA

被引：18

作者：

KENNEDY, BJ

THEOLOGIDES, A

机构：

来源：

关键词：

D O I：

10.1056/NEJM196104202641603

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：790 / &

共 10 条

[1]

EVANS JS, 1958, P SOC EXP BIOL MED, V99, P620

[2]

KENNEDY BJ, 1960, CLIN RES, V8, P251

[3]

LANE M, 1960, CANCER RES, V20, P511

[4]

LANE M, 1958, CLIN RES, V7, P46

[5]

LANE MONTAGUE, 1959, PROC AMER ASSOC CANCER RES, V3, P35

[6]

LANE MONTAGUE, 1960, CANCER CHEMOTHERAPY REPTS, V9, P31

[7] 5-BIS-(2-CHLOROETHYL)-AMINOURACIL, A NEW ANTITUMOR AGENT [J].

LYTTLE, DA ;

PETERING, HG .

[8]

LYTTLE DA, 1959, J NATL CANCER I, V23, P153

SHANBROM, E ;

MILLER, S ;

HAAR, H ;

OPFELL, R .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1960, 174 (13) :1702-1705

[10]

SHANBROM E, 1959, CLIN RES, V7, P57